Clinician Practice Companion to Address Youth Substance Use (NCT07725289)
๐ฉบ Plain-English Summary (8th-Grade Level)
Substance use, including the use of opioids, cannabis, and other drugs, is common among adolescents and young adults, and overdose has become a leading cause of death among youth in Canada and the United States. Many young people who use substances also experience co-occurring mental health concerns. Evidence-based approaches to youth substance use care exist, including harm reduction, overdose prevention (such as naloxone and take-home drug testing strips), and medications for addiction treatment. These approaches remain adult-oriented, however, unevenly implemented in youth-serving settings, and insufficiently centered on the needs and goals of youth and their families. This study develops and pilot tests a written "practice companion" that helps clinicians and other trusted adults provide developmentally appropriate substance use care to youth ages 14 to 24 in hospital and community settings. The practice companion offers practical, easy-to-use guidance organized by substance and by pattern of use. It addresses cannabis and other substances that youth commonly use and that clinicians frequently seek support with, alongside a strong focus on overdose prevention through its core elements: naloxone, take-home drug testing strips, harm reduction education, and medications for opioid use disorder. It also attends to co-occurring mental health needs and to how gender, sexuality, housing instability, and other social and structural contexts shape substance use and care. The research team will first interview youth who use substances, their families and caregivers, and clinicians to learn how each element of care should be adapted for young people. The team will then produce the practice companion and pilot test it with 60 youth across three sites, in British Columbia, Quรฉbec, and Massachusetts. After receiving care guided by the practice companion, youth will complete an interview about whether the care was relevant, useful, appropriate, and acceptable. Families and clinicians will also be interviewed to assess how feasible, sustainable, and faithful to its design the practice companion is in practice. Throughout the study, the team will work closely with youth and families who have lived experience through a community-based participatory research approach that includes Community Advisory Boards. The work centers equity for Black, Indigenous, and other racialized youth, Two-Spirit and LGBTQ+ youth, and youth experiencing housing instability. Findings will guide a larger future study of the practice companion's effectiveness.
Who can join: Review the eligibility criteria below.
Location: Adolescent and Young Adult Medicine, Mass General Brigham for Children โ Boston, Massachusetts
Age range: 14 Years to 24 Years
๐งช Interventions in This Study
- Practice Companion (BEHAVIORAL)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (5 Sites)
- Adolescent and Young Adult Medicine, Mass General Brigham for Children โ Boston, Massachusetts
- BC Children's Hospital โ Vancouver, British Columbia
- Foundry (Foundry Central Office) โ Vancouver, British Columbia
- Centre de Recherche du CHUM (CRCHUM) โ Montreal, Quebec
- CHU Sainte-Justine โ Montreal, Quebec
๐ Contact the Study Coordinator
Phone: (604) 875-2345
Email: danya.fast@ubc.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Substance Use
- The Substance Abuse Treatment to HIV Care II (SAT2HIV-II) Project โ Columbus, Ohio
- Expanding the Potential of Couples HIV Testing: Adjunct Modules to Reduce Drug Use Among Vulnerable Male Couples โ Ann Arbor, Michigan
- Substance Use Treatment and Its Role in Supporting Social Cognition โ Fort Lauderdale, Florida
- Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care) โ Torrance, California
- Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders โ Ann Arbor, Michigan
- Community Driven Substance Use Recovery for High Opioid Overdose Areas โ Bridgeport, Connecticut
Explore by condition: All Substance Use clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.